Applied Clinical Trials
Using a specific trial, the importance of assessing the success of therapy masking is examined.
Ruth McBride
Advertisement
Ruth McBride, BS, is chief technology officer with Axio Research Corporation, a division of Solutia Pharmaceutical Services Division, 2601 4th Avenue, Suite 200, Seattle, WA, 98121, (206) 577-0217, fax (206) 547-4671, email: [email protected].
Articles by Ruth McBride
Applied Clinical Trials
An important criterion for a well-conducted clinical trial is minimization of bias in endpoint assessment.
Advertisement
Latest Updated Articles
Evaluating the Effects of Therapy MaskingMarch 13th 2015
Evaluating the Effects of Therapy MaskingOctober 1st 2015
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
2
2026 DIA Global Annual Meeting: Stacy Hurt of Parexel on Federated AI, the Patient Voice, and Accountability for Patient Needs
3
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
4
2026 DIA Global Annual Meeting: How Structured Protocols Enable Automated Amendments and Real-Time FDA Oversight
5